- Home
- ARQ vs ABEO Comparison
ARQ vs ABEO Comparison
Compare ARQ & ABEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARQ
- ABEO
- Stock Information
- Founded
- ARQ 1996
- ABEO N/A
- Country
- ARQ United States
- ABEO United States
- Employees
- ARQ N/A
- ABEO N/A
- Industry
- ARQ
- ABEO Biotechnology: Pharmaceutical Preparations
- Sector
- ARQ
- ABEO Health Care
- Exchange
- ARQ NYSE
- ABEO Nasdaq
- Market Cap
- ARQ 249.0M
- ABEO 243.9M
- IPO Year
- ARQ N/A
- ABEO 1980
- Fundamental
- Price
- ARQ $5.60
- ABEO $6.43
- Analyst Decision
- ARQ
- ABEO Strong Buy
- Analyst Count
- ARQ 0
- ABEO 3
- Target Price
- ARQ N/A
- ABEO $18.00
- AVG Volume (30 Days)
- ARQ 355.3K
- ABEO 248.5K
- Earning Date
- ARQ 08-12-2024
- ABEO 11-11-2024
- Dividend Yield
- ARQ N/A
- ABEO N/A
- EPS Growth
- ARQ N/A
- ABEO N/A
- EPS
- ARQ N/A
- ABEO N/A
- Revenue
- ARQ $105,078,000.00
- ABEO N/A
- Revenue This Year
- ARQ $4.58
- ABEO N/A
- Revenue Next Year
- ARQ $40.31
- ABEO $7,097.06
- P/E Ratio
- ARQ N/A
- ABEO N/A
- Revenue Growth
- ARQ 12.87
- ABEO 147.52
- 52 Week Low
- ARQ $1.60
- ABEO $3.05
- 52 Week High
- ARQ $8.26
- ABEO $9.01
- Technical
- Relative Strength Index (RSI)
- ARQ 45.86
- ABEO 66.16
- Support Level
- ARQ $5.33
- ABEO $6.06
- Resistance Level
- ARQ $5.78
- ABEO $6.60
- Average True Range (ATR)
- ARQ 0.34
- ABEO 0.31
- MACD
- ARQ 0.01
- ABEO 0.04
- Stochastic Oscillator
- ARQ 55.83
- ABEO 85.47
About ARQ ARQ INC
Arq Inc is an environmental technology company principally engaged in the sale of consumable air, water, and soil treatment solutions including activated carbon (AC) and chemical technologies. The company manufactures and sells activated carbon and other chemicals used to capture and remove contaminants for the coal-fired power generation, industrial, municipal water and air, water and soil treatment and remediation markets. Some of the products in its portfolio are Powdered Activated Carbon, Granular Activated Carbon, and Colloidal Carbon Product among others.
About ABEO Abeona Therapeutics Inc.
Abeona Therapeutics Inc is a clinical-stage biopharmaceutical company. The firm is focused on developing gene therapies and plasma-based products for life-threatening rare genetic diseases. Its clinical programs consist of pz-cel, an autologous, engineered cell therapy currently in development for recessive dystrophic epidermolysis bullosa (RDEB). The Company's development portfolio also features adeno-associated virus (AAV)-based gene therapies designed to treat unmet, medically needed ophthalmic diseases using the novel AIM.